FindTrial
Sign In

Histopathological changes in placenta in COVID 19 mothers.

Study of placental histopathology in COVID 19 mothers at dedicated COVID 19 hospital in India.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/033193
Enrollment
100
Registered
2021-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: O43- Placental disorders Health Condition 3: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Control Intervention1: nil: nil

Sponsors

Dr Shilpa K lad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Placentas delivered of all Pregnant women with SARS COV2 infection (Positive on RT-PCR) will be included. All abortions and still births will be included

Exclusion criteria

Exclusion criteria: Anemryogenic pregnancies will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Generate a comprehensive overview of SARS-CoV-2 infection, COVID 19 complications and changes seen in placenta.Timepoint: Data will be analysed at 3 monthly intervals—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Shilpa Kapil Lad

T N Medical Colleg and B Y L Nair Ch hospital

drshilpaklad@yahoo.com9820827567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026